title: [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].
abstract: This report summarizes the relevant aspects of the S2e guideline of the German Urologists for the conservative and pharmacological treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Recommendations are given regarding watchful waiting, behavioral therapy, phytotherapy and pharmacological mono- and combination therapy. The influence of the different therapeutic options on bladder outlet obstruction (BOO) is described in detail.
authors.affiliation: Klinik für Urologie, Evangelisches Krankenhaus Oberhausen, Virchowstraße 20, 46047, Oberhausen, Deutschland. klaus.hoefner@eko.de.
authors.forename: K
authors.initials: K
authors.lastname: Höfner
authors.affiliation: Abteilung für Urologie, Asklepios Klinikum Harburg, Hamburg, Deutschland.
authors.forename: T
authors.initials: T
authors.lastname: Bach
authors.affiliation: Gemeinschaftspraxis Urologische und Andrologische Diagnose und Therapie, PAN-Klinik, Köln, Deutschland.
authors.forename: R
authors.initials: R
authors.lastname: Berges
authors.affiliation: Ärztezentrum Horn, Bremen, Deutschland.
authors.forename: K
authors.initials: K
authors.lastname: Dreikorn
authors.affiliation: Urologische Klinik und Poliklinik, Klinikum der LMU München, München, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Gratzke
authors.affiliation: Abteilung für Urologie, Kaiser-Franz-Josef-Spital, Wien, Österreich.
authors.forename: S
authors.initials: S
authors.lastname: Madersbacher
authors.affiliation: Klinik für Urologie, Universitätsmedizin Mannheim, Mannheim, Deutschland.
authors.forename: M-S
authors.initials: MS
authors.lastname: Michel
authors.affiliation: Klinik für Urologie und Kinderurologie, Agaplesion Diakonieklinikum Rotenburg gemeinnützige GmbH, Rotenburg (Wümme), Deutschland.
authors.forename: R
authors.initials: R
authors.lastname: Muschter
authors.affiliation: Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Oelke
authors.affiliation: Klinik für Urologie, Klinikum Harlaching; Städtisches Klinikum München, München, Deutschland.
authors.forename: O
authors.initials: O
authors.lastname: Reich
authors.affiliation: Urologische Gemeinschaftspraxis, Münster, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Tschuschke
authors.affiliation: Klinik für Urologie, Andrologie und Kinderurologie, Klinikum Weiden/Kliniken Nordoberpfalz AG, Weiden, Deutschland.
authors.forename: T
authors.initials: T
authors.lastname: Bschleipfer
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001521:Behavior Therapy / Q000592:standards*; D019317:Evidence-Based Medicine; D005858:Germany; D006801:Humans; D008297:Male; D008517:Phytotherapy / Q000592:standards; D017410:Practice Guidelines as Topic; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D016896:Treatment Outcome; D001748:Urinary Bladder Neck Obstruction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D014572:Urology / Q000592:standards; D057832:Watchful Waiting / Q000592:standards*
chemical_list: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists
keywords: Behavioral therapy; Drug therapy, combination; Monotherapy, drug; Phytotherapy; Watchful waiting